Upgrade to SI Premium - Free Trial

Karyopharm Therapeutics (KPTI) PT Raised to $37 at RBC Capital

March 2, 2020 1:12 PM
RBC Capital analyst Brian Abrahams raised the price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles